is semaglutide fda approved for mash The has Wegovy (semaglutide) as a treatment metabolic-associated steatohepatitis (MASH) with moderate-to-advanced scarring, a serious liver condition affecting approximately 6% of US adults. Key highlights of drug development program Big news in liver health!

Inverse-variance weighting was applied using the SEM of each observation

Wada, T

The EEG assessment of low-grade hepatic encephalopathy: comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis

64,65 In particular, because CKD contributes to the progression of cardiovascular disease through many pathways, the authors of a 2021 review published in Circulation stated that CKD mimics an accelerated aging of the cardiovascular system. 66 Blood Clot and Bleeding Risks Chronic kidney disease increases the risk of bleeding events as well as blood clots (thrombosis) and related health problems